REFERENCES
- Lee H. J. M. Taylor, G. AmidonBiopharmaceutical properties and pharmacokinetics of peptide and protein drugs. Peptide-Based Drug Design, . American Chemical Society, WashingtonDC 1995; 69–97
- Sanders L. M. Drug delivery systems and routes of administration of peptide and protein drugs. Eur. J. Drug Metab. Pharmacokinet 1990; 15(2)95–102
- Hora M. S., Rana R. K., Tafaro T. A., Nunberg H. J., Tice R. R., Gilley R. M., Hudson M. E. Development of a controlled release microspheres formulation of interleukin-2. Proc. Int. Symp. Controlled Release Bioact. Mater. 1989; 16: 509–510
- Talmadge J. E. The pharmaceutics and delivery of therapeutic polypeptides and proteins. Adv. Drug Del. Rev. 1993; 10: 247–299
- Okada H., Toguchi H. Biodegradable microspheres in drug delivery. Crit. Rev. Ther. Drug Carrier Sys. 1995; 12(1)1–99
- Heya T., Okada H., Ogawa Y., Toguchi H. In vitro and in vivo evaluation of thyrotrophin releasing hormone release from copoly(dl-lactic/glycolic acid) microspheres. J. Pharm. Sci. 1994; 83(5)636–640
- Cohen S., Yoshioka T., Lucarelli M., Hwang L. H., Langer R. Controlled delivery systems for proteins based on poly(lactic/glycolic acid) microspheres. Pharm. Res. 1991; 8(6)713–720
- Mehta R. C., Jeyanthi R., Calis S., Thanoo B. C., Burton K. W., DeLuca P. P. Biodegradable microspheres as depot system for parenteral delivery of peptide drugs. J. Controlled Release 1994; 29: 375–384
- Okada H., Doken Y., Ogawa Y., Toguchi H. Preparation of three-month depot injectable microspheres of leuprorelin acetate using biodegradable polymers. Pharm. Res. 1994; 11(8)1143–1147
- Asch R. H., Rojas F. J., Bartke A., Schally A. V., Tice T. R., Klemcke H. G., Silerkhodr T. M., Bray R. E., Hogan M. P. Prolonged suppression of plasma LH levels in male rats after a single injection of an LHRH agonist in poly(dl-lactide-co-glycolide) microcapsules. J. Androl. 1985; 6: 83–88
- Walker K. J., Turkes A. O., Turkes A., Zwink R., Beacock C., Buck A., Peeling W. B., Griffiths K. Treatment of patients with advanced cancer of prostate using a slow-release (depot) formulation of the LHRH agonist ICI 118630 (Zoladex). J. Endocrinol. 1984; 103: R1
- Cutwright D. E., Perez E., Beasley J. D., Larson W. J., Posey W. R. Degradation of polylactic acid polymer and copolymers of poly(glycolic acid). J. Oral Surg. 1974; 37: 142–152
- Park T. G. Degradation of poly(dl-lactic acid) microspheres: effect of molecular weight. J. Controlled Release 1994; 30: 161–173
- Kissel T., Brich Z., Bantle S., Lancranjan I., Nimmerfall F., Vit P. Parenteral depot systems on the basis of biodegradable polyesters. J. Controlled Release 1991; 16: 27–42
- Bodmer D., Kissel T., Traechslin E. Factors influencing the release of peptides and proteins from biodegradable parenteral depot systems. J. Controlled Release 1992; 21: 129–138
- Washington C. Drug release from microdisperse systems: a critical review. Int. J. Pharm. 1990; 58: 1–12
- Sah H., Toddywala R., Chien Y. W. The influence of biodegradable microcapsule formulations on the controlled release of a protein. J. Controlled Release 1994; 30: 201–211
- Shah S. S., Cha Y., Pitt C. G. Poly(glycolic acid-co-dl-lactic acid): Diffusion or degradation controlled drug delivery?. J. Controlled Release 1992; 18: 261–270
- Hadgraft J., Guy R. H. L. Illum, S. S. DavisRelease and diffusion of drugs from polymers. Polymers in Controlled Drug Delivery, . Wright, Bristol 1987; 99–116
- Heya T., Okada H., Tanigawara Y., Ogawa Y., Toguchi H. Effects of counterion of TRH and loading amount on control of TRH release from copoly(dl-lactic/glycolic acid) microspheres prepared by an in-water drying method. Int. J. Pharm. 1991; 69: 69–75
- Alanso M. J., Cohen S., Park T. G., Gupta R. K., Siber G. R., Langer R. Determinants of release rate of tetanus vaccine from polyester microspheres. Pharm. Res. 1993; 10(7)945–953
- DeLuca P. P., Kanke M., Sato T., Schroeder H. G. Porous microspheres for drug delivery and methods for making same. U.S. Patent 4,818, 542, 1990
- Ogawa Y., Yamamoto M., Okada H., Yashiki T., Shimamoto T. A new technique to efficiently entrap leuprolide acetate into microspheres of polylactic acid or copoly(lactic/glycolic) acid. Chem. Pharm. Bull. 1988; 3: 1095–1103
- Guide for the Care and Use of Laboratory Animals. DHEW Pub. No. 78–23 (revised), National Institutes of Health
- Okada H., Inoue Y., Heya T., Ueno H., Ogawa Y., Toguchi H. Pharmacokinetics of once-a-month injectable microspheres of leuprolide acetate. Pharm. Res. 1991; 8(6)787–791
- Bodmeier R., McGinity J. W. Polylactic acid microspheres containing quinidine base and quinidine sulfate prepared by the solvent evaporation technique I. Methods and morphology. J. Microencap. 1987; 4: 279–288
- Iwata M., McGinity J. W. Preparation of multiphase microspheres of poly(d,l-lactic acid) and poly(d,l-lactic-co-glycolic acid) containing a w/o emulsion by multiple emulsion solvent evaporation technique. J. Microencap. 1992; 9: 201–214
- Juni K., Ogata J., Matsui N., Kubota M., Nakano M. Control of release rate of bleomycin from polylactic acid microspheres by additives. Chem. Pharm. Bull. 1985; 33(4)1609–1614
- Herrmann J., Bodmeier R. The effect of particle microstructure on the somatostatin release from poly (lactide) microspheres prepared by a w/o/w solvent evaporation method. J. Controlled Release 1995; 36: 63–71